• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Treating Hyperhidrosis: Glycopyrronium Tosylate

Video

Shawn Davis, PharmD: Glycopyrronium tosylate is an exciting therapy that will enable patients to have something topical. This is something that I believe is going to help patients. It is really going to have an impact on their lives and change the way that they live their lives.

Glycopyrronium tosylate is a medication that is actually going to meet the needs of patients in a way that they don’t have today. There aren’t good therapies on the market for patients to treat their hyperhidrosis and the condition that they have.

The next part is going to really be seeing what managed care’s outlook will be in paying for these medications. We are going to have a therapy. Just like with all therapies that are on the market, how do we pay for it? What’s going to be the mechanism by which payers and patients split the cost?


Related Videos
Video 1 - "Diagnosing and Understanding the Pathogenesis of Bronchiectasis"
Video 4 - "Challenges in Autoantibody Screening for Type 1 Diabetes"
Jeff Stark, MD, vice president, head of medical immunology, UCB
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 7 - "Prior Authorization and Access to Targeted Treatment for Ph+ ALL Patients"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Video 6 - "Community Partnership: Increasing Public Awareness of CVD"
Screenshot of Raajit Rampal, MD, PhD
 Laura Ferris, MD, PhD, professor of dermatology, University of Pittsburgh
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.